Key result
Novel and repurposed antiviral combinations were administered to eight immunocompromised patients with severe enterovirus infections in a UK case series.
Why the study?
Novel antiviral treatments are badly needed for severe enterovirus infections.
Describes a case series of 8 immunocompromised patients treated with novel and repurposed antiviral combinations for severe enterovirus infection.
Hypothesis-generating for antiviral combinations in severe enterovirus; prospective trials needed before clinical adoption.
Previously in this Journal, it was pointed out that novel antiviral treatments are badly needed for severe enterovirus infections1. We describe eight immunocompromised individuals who received antiviral combinations with novel and repurposed agents in UK (Table 1).
No takes yet. Share an insight, caveat, or question.
Meinhardt et al. (2024) studied this question. Novel and repurposed antiviral combinations were administered to eight immunocompromised patients with severe enterovirus infections in a UK case series.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: